F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:F1 Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11119
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
F1 Oncology Inc (F1 Oncology) is a developer of adoptive cellular therapy candidates. The company develops CAB technology to mitigate the on-target, off-tumor toxicity of Chimeric Antigen Receptor (CAR) T cell therapy. It is developing CAB technology. The company’s drugs are used in rewiring the molecular circuitry of the immune system to target some of the most challenging solid tumor malignancies. It has operational presence in San Diego, California, Cayman Islands, Hong Kong and Shanghai. F1 Oncology is headquartered in West Palm Beach, Florida, the US.

F1 Oncology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F1 Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
F1 Oncology Raises USD40 Million in Venture Financing 10
Partnerships 11
F1 Oncology and Shanghai Sinobioway Sunterra Biotechnology Enter into Agreement 11
Licensing Agreements 12
F1 Oncology Enters into Licensing Agreement with BioAtla 12
Equity Offering 13
F1 Oncology Raises USD10 Million in Private Placement of Shares 13
F1 Oncology Inc – Key Competitors 14
F1 Oncology Inc – Key Employees 15
F1 Oncology Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
F1 Oncology Inc, Pharmaceuticals & Healthcare, Key Facts 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F1 Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F1 Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
F1 Oncology Raises USD40 Million in Venture Financing 10
F1 Oncology and Shanghai Sinobioway Sunterra Biotechnology Enter into Agreement 11
F1 Oncology Enters into Licensing Agreement with BioAtla 12
F1 Oncology Raises USD10 Million in Private Placement of Shares 13
F1 Oncology Inc, Key Competitors 14
F1 Oncology Inc, Key Employees 15
F1 Oncology Inc, Other Locations 16

List of Figures
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
F1 Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[F1 Oncology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intellipharmaceutics International Inc (IPCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company that researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosa …
  • CF Industries Holdings Inc (CF):企業の財務・戦略的SWOT分析
    CF Industries Holdings Inc (CF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Informatica Corporation:企業のM&A・事業提携・投資動向
    Informatica Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Informatica Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Intercontinental Hotels Group Plc:企業の戦略・SWOT・財務分析
    Intercontinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report Summary Intercontinental Hotels Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SRI International:医療機器:M&Aディール及び事業提携情報
    Summary SRI International (SRI) is a non-profit organization that provides commercial research and development programs. The organization’s services include research and development, innovation consulting, technology solutions, bioscience contract research, specialized facilities and services. It pe …
  • HeidelbergCement AG:戦略・SWOT・企業財務分析
    HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report Summary HeidelbergCement AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Novavax Inc (NVAX):製薬・医療:M&Aディール及び事業提携情報
    Summary Novavax Inc (Novavax) is a clinical-stage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccine …
  • Mach7 Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mach7 Technologies Inc (Mach7) is a healthcare technology company that offers enterprise image management solutions. The company offers solutions such as archive and communication, access and share, manage data and services. Its products include communication workflow engine, vendor neutral …
  • Cogstate Ltd (CGS):企業の財務・戦略的SWOT分析
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • Austrian Post:企業の戦略・SWOT・財務情報
    Austrian Post - Strategy, SWOT and Corporate Finance Report Summary Austrian Post - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Meiji Holdings Co, Ltd.:戦略・SWOT・企業財務分析
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AerCap Holdings NV:企業の戦略・SWOT・財務情報
    AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report Summary AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Consolidated Edison Inc (ED):企業の財務・戦略的SWOT分析
    Consolidated Edison Inc (ED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Coresa Sa
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • The Clorox Company:戦略・SWOT・企業財務分析
    The Clorox Company - Strategy, SWOT and Corporate Finance Report Summary The Clorox Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Greencore Group Plc:企業のM&A・事業提携・投資動向
    Greencore Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Greencore Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • ADDvise Group AB (ADDV A):医療機器:M&Aディール及び事業提携情報
    Summary ADDvise Group AB (ADDvise), formerly ADDvise Lab Solutions AB, is a medical device company that manufactures and markets healthcare and laboratory equipment. The company offers laboratory products such as laboratory equipments, furnishings, safety ventilation, centrifuges, climate chambers, …
  • Energias de Portugal S.A:企業の戦略・SWOT・財務分析
    Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report Summary Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Drexel University:製薬・医療:M&Aディール及び事業提携情報
    Summary Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It …
  • SomaLogic Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆